SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · CH

BB Biotech AG backtest

10 trend-following strategies were compared on the full daily history of BB Biotech AG. 5 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is MACD (CAGR 4.6%, MDD -40.9%).

Data 2000-01-04 ~ 2026-09-30daily bars 6,787 (26.7 years)Costs 0.5%Venue SIXMonthly snapshot 2026-09-30

Results by strategy

5 of 10 beat buy and hold (CAGR 3.4%, drawdown -82.0%).

Sharpe leader (same as main): Supertrend — CAGR 6.2%, MDD -45.6%, Sharpe 0.42, 52% exposure.

Return/drawdown alternative: MACD — CAGR is 2.8%p higher than buy and hold, while drawdown improves by 36.4%p (CAGR 4.6%, MDD -40.9%, exposure 51%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=11, mult=3.6
6.2%-45.6%0.420.145.0x15452%
EMA 크로스오버
fast=13, slow=203
4.6%-50.4%0.350.093.4x6353%
Donchian 채널 돌파
entryN=11, exitN=48
5.5%-68.8%0.340.084.2x9979%
MACD
fast=24, slow=56, signal=21
4.6%-40.9%0.340.113.3x21051%
SMA 크로스오버
fast=28, slow=205
4.0%-49.5%0.310.082.9x4553%
볼린저 밴드 돌파
n=68, k=1.8
3.2%-48.5%0.300.072.3x8834%
ROC 모멘텀
n=141, threshold=-0.06
2.5%-57.7%0.220.041.9x13966%
Keltner 채널 돌파
emaPeriod=12, atrPeriod=12, mult=3.7
0.7%-26.0%0.150.031.2x41%
Parabolic SAR
step=0.005, maxStep=0.38
0.9%-74.0%0.140.011.3x22253%
ADX / DI 방향성
period=19, threshold=12
-2.2%-72.0%-0.05-0.030.5x44242%
Buy and hold3.4%-82.0%0.260.042.4x1100%
1x 2001 2005 2009 2013 2017 2021 2025 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -21% -41% -62% -82% 2001 2005 2009 2013 2017 2021 2025 Buy and holdSupertrend
Supertrend maximum drawdown -45.6% (2001-06-11 → 2011-09-05), recovered after 4,272 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 120 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore CH assetsAll asset reports

Read next